Jiangsu Grand Xianle Pharmaceutical is an API manufacturer based in China. It holds one active US drug master file and 5 valid CEPs across a filed portfolio of 6 molecules. Its GMP standing is certified by EMA.
| Site | FDA FEI |
|---|---|
| Yancheng, China | Not on file |
| Yancheng City, China | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Betamethasone | EDQM | 1 |
| Clobetasol Propionate | EDQM | 1 |
| Cyproterone | EDQM | 1 |
| Medroxyprogesterone Acetate | EDQM | 1 |
| Megestrol Acetate | US FDA | 1 |
| Prednisolone | EDQM | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| EMA | None | 2 |
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Ask Fred what the record holds on Jiangsu Grand Xianle Pharmaceutical, including filings and inspection history.
Chat with Fred, your AI analystRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.